Ceftazidime Qilu

Medicinal product

(Invented) name

Ceftazidime Qilu

Active substance (s)

Ceftazidimas

Strength

1 g

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DD02, Ceftazidime

Marketing authorisation holder

QILU PHARMA SPAIN S.L., Ispanija

Date of authorisation

2022-02-22

Date of renewal

2022-12-08

Documents

4907 Ceftazidime Qilu PCS PL 2024 10 09.docx

4907 Pakuotės lapelis 2024 10 09.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

ES/H/0706/002/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Ceftazidimas	1 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108113	94217	1094217	flakonas	N1		Receptinis	LT/1/22/4907/001	Netiekiama	-	-	No	-	-	Download
108114	94218	1094218	flakonas	N10		Receptinis	LT/1/22/4907/002	Netiekiama	-	-	No	-	-	Download
108115	94219	1094219	flakonas	N50		Receptinis	LT/1/22/4907/003	Tiekiama	2025-09-15	-	No	-	-	Download

Stadijos

Data	Stadija
2022-12-08	Perregistruotas
2022-02-22	Registruotas